BACKGROUND: Atrial fibrillation (AF) and related atrial tachyarrhythmias (AT), including type I atrial flutter (AFL) are frequently observed in patients with pulmonary hypertension (PH). Their relationship to hemodynamic changes, atrial size, and ventricular function are still not fully verified. METHODS: We retrospectively studied hemodynamic data, echocardiographic findings and arrhythmia incidence in 814 patients with invasively diagnosed precapillary PH (aged 59 ± 14 years; 46% males). Patients with combined or post-capillary PH were excluded. RESULTS: AF / AT were identified in 225 (28%) of all the study population. Compared to the subgroup without arrhythmia, patients with AF / AT had elevated right atrial pressure (11 ± 5 vs. 9 ± 5 mmHg), wedge pressure (11 ± 3 vs. 10 ± 3), a more enlarged right atrium (50 ± 12 vs. 47 ± 11 mm) and an increased left atrial diameter in the parasternal long axis projection, p < 0.05 for all comparisons. In the multivariate model, the left atrial size, patient age, arterial hypertension, diabetes and type of PH were associated with AF / AT occurrence, p < 0.05. Patients with type I AFL were more frequently male (39 (80%) vs. 62 (42%)), were younger (61 ± 11 vs. 67 ± 10 years), had increased pulmonary artery mean pressure (50 ± 12 vs. 45 ± 12 mmHg), less advanced left atrial dilatation (38 ± 10 vs. 42 ± 7 mm), and a more enlarged right atrium (56 ± 12 vs. 48 ± 11) as compared to subjects with AF or other AT, p < 0.05. CONCLUSIONS: The evidence of elevated wedge pressure and the enlargement of the left atrium especially in patients with AF suggest a parallel involvement of the left atrial substrate in arrhythmia formation despite invasively confirmed evidence of purely isolated precapillary PH. Substantial differences were noticed between patients with type I AFL and the remaining patients with other arrhythmia types.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University Prague U Nemocnice 2 12808 Prague Czech Republic

2nd Department of Medicine Department of Cardiovascular Medicine General University Hospital Prague U Nemocnice 2 12808 Prague Czech Republic

Zobrazit více v PubMed

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37(1):67–119. doi: 10.1093/eurheartj/ehv317. PubMed DOI

Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S. doi: 10.1016/j.jacc.2004.02.037. PubMed DOI

Wen L, Sun ML, An P, Jiang X, Sun K, Zheng L, et al. Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol. 2014;114(9):1420–1425. doi: 10.1016/j.amjcard.2014.07.079. PubMed DOI

Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013;167(5):2300–2305. doi: 10.1016/j.ijcard.2012.06.024. PubMed DOI

Ruiz-Cano MJ, Gonzalez-Mansilla A, Escribano P, Delgado J, Arribas F, Torres J, et al. Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension. Int J Cardiol. 2011;146(1):105–106. doi: 10.1016/j.ijcard.2010.09.065. PubMed DOI

Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp JM, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J. 2007;153(1):127–132. doi: 10.1016/j.ahj.2006.09.008. PubMed DOI

Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19(12):1845–1855. doi: 10.1053/euhj.1998.1046. PubMed DOI

Rottlaender D, Motloch LJ, Schmidt D, Reda S, Larbig R, Wolny M, et al. Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS One. 2012;7(3):e33902. doi: 10.1371/journal.pone.0033902. PubMed DOI PMC

Waligora M, Tyrka A, Miszalski-Jamka T, Urbanczyk-Zawadzka M, Podolec P, Kopec G. Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension. Heart Lung. 2018;47(3):237–242. doi: 10.1016/j.hrtlng.2018.01.004. PubMed DOI

Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J. 2009;30(20):2493–2537. doi: 10.1093/eurheartj/ehp297. PubMed DOI

Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J. 2004;25(24):2243–2278. doi: 10.1016/j.ehj.2004.09.014. PubMed DOI

Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2016;13(4):e136–e221. doi: 10.1016/j.hrthm.2015.09.019. PubMed DOI

Showkathali R, Tayebjee MH, Grapsa J, Alzetani M, Nihoyannopoulos P, Howard LS, et al. Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension. Int J Cardiol. 2011;149(2):279–280. doi: 10.1016/j.ijcard.2011.02.059. PubMed DOI

Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):25S–32S. doi: 10.1016/j.jacc.2004.02.033. PubMed DOI

Medi C, Kalman JM, Ling LH, Teh AW, Lee G, Lee G, et al. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol. 2012;23(6):614–620. doi: 10.1111/j.1540-8167.2011.02255.x. PubMed DOI

Folino AF, Bobbo F, Schiraldi C, Tona F, Romano S, Buja G, et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung. 2003;181(6):321–328. doi: 10.1007/s00408-003-1034-x. PubMed DOI

Schrier RW, Bansal S. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol. 2008;3(5):1232–1237. doi: 10.2215/CJN.01960408. PubMed DOI PMC

Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994;5(2):182–209. doi: 10.1111/j.1540-8167.1994.tb01157.x. PubMed DOI

Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96(9):3157–3163. doi: 10.1161/01.CIR.96.9.3157. PubMed DOI

Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3(5):588–595. doi: 10.1161/CIRCHEARTFAILURE.109.930701. PubMed DOI PMC

D'Alto M, Romeo E, Argiento P, Motoji Y, Correra A, Di Marco GM, et al. Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension. Chest. 2017;151(1):119–126. doi: 10.1016/j.chest.2016.08.1439. PubMed DOI

Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, et al. Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum. J Am Coll Cardiol. 2016;68(4):368–378. doi: 10.1016/j.jacc.2016.05.047. PubMed DOI

Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37(12):942–954. doi: 10.1093/eurheartj/ehv512. PubMed DOI PMC

Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954–1968. doi: 10.1161/01.CIR.92.7.1954. PubMed DOI

Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm. 2009;6(4):454–460. doi: 10.1016/j.hrthm.2009.01.010. PubMed DOI PMC

Chimenti C, Russo MA, Carpi A, Frustaci A. Histological substrate of human atrial fibrillation. Biomed Pharmacother. 2010;64(3):177–183. doi: 10.1016/j.biopha.2009.09.017. PubMed DOI

Mahnkopf Christian, Badger Troy J., Burgon Nathan S., Daccarett Marcos, Haslam Thomas S., Badger Christopher T., McGann Christopher J., Akoum Nazem, Kholmovski Eugene, Macleod Rob S., Marrouche Nassir F. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: Implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7(10):1475–1481. doi: 10.1016/j.hrthm.2010.06.030. PubMed DOI PMC

Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758–1767. doi: 10.1161/CIRCULATIONAHA.108.811877. PubMed DOI PMC

Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right atrial remodeling is more advanced in patients with atrial flutter than with atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(10):1067–1072. doi: 10.1111/j.1540-8167.2012.02364.x. PubMed DOI

The impact of atrial fibrillation and atrial tachycardias on the hemodynamic status of patients with pulmonary hypertension

The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy